Maria Luisa Brandi

Research interests

Publications

• Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials

  BMJ · 2023 · https://doi.org/10.1136/bmj-2021-068033

• Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with microRNAs

  International Journal of Molecular Sciences · 2023 · https://doi.org/10.3390/ijms24043772

• Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop

  Journal of Bone and Mineral Research · 2020 · https://doi.org/10.1002/jbmr.4677

• Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia

  Nature Reviews Nephrology · 2019 · https://doi.org/10.1038/s41581-019-0152-5

• Pitfalls in the measurement of muscle mass: a need for a reference standard

  Journal of Cachexia Sarcopenia and Muscle · 2018 · https://doi.org/10.1002/jcsm.12268

• The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases

  Nature Reviews Endocrinology · 2018 · https://doi.org/10.1038/s41574-018-0115-0

• Does nutrition play a role in the prevention and management of sarcopenia?

  Clinical Nutrition · 2017 · https://doi.org/10.1016/j.clnu.2017.08.016

• Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

  New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1708322

• Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting

  Osteoporosis International · 2017 · https://doi.org/10.1007/s00198-017-4009-0

• 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

  The Lancet Diabetes & Endocrinology · 2017 · https://doi.org/10.1016/s2213-8587(17)30138-9

• Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus

  Osteoporosis International · 2016 · https://doi.org/10.1007/s00198-016-3716-2

• Management of Hypoparathyroidism: Summary Statement and Guidelines

  The Journal of Clinical Endocrinology & Metabolism · 2016 · https://doi.org/10.1210/jc.2015-3907

• Sarcopenia in daily practice: assessment and management

  BMC Geriatrics · 2016 · https://doi.org/10.1186/s12877-016-0349-4

• Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice

  Bone · 2015 · https://doi.org/10.1016/j.bone.2015.05.016

• Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop

  The Journal of Clinical Endocrinology & Metabolism · 2014 · https://doi.org/10.1210/jc.2014-1413

• Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus

  Journal of Bone and Mineral Research · 2014 · https://doi.org/10.1002/jbmr.2405

• An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

  Seminars in Arthritis and Rheumatism · 2014 · https://doi.org/10.1016/j.semarthrit.2014.05.014

• Quality of Life in Sarcopenia and Frailty

  Calcified Tissue International · 2013 · https://doi.org/10.1007/s00223-013-9758-y

• ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes

  Neuroendocrinology · 2012 · https://doi.org/10.1159/000335591

• Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)

  The Journal of Clinical Endocrinology & Metabolism · 2012 · https://doi.org/10.1210/jc.2012-1230

• Antidepressant medications and osteoporosis

  Bone · 2012 · https://doi.org/10.1016/j.bone.2012.05.018

• Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture

  Nature Genetics · 2012 · 10.1038/ng.2249

• Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research

  Journal of Bone and Mineral Research · 2011 · https://doi.org/10.1002/jbmr.483

• Osteogenic Differentiation of Human Adipose Tissue-Derived Stem Cells Is Modulated by the miR-26a Targeting of the SMAD1 Transcription Factor

  Journal of Bone and Mineral Research · 2007 · https://doi.org/10.1359/jbmr.071011

• Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density

  New England Journal of Medicine · 2002 · https://doi.org/10.1056/nejmoa011807

• CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2

  The Journal of Clinical Endocrinology & Metabolism · 2001 · https://doi.org/10.1210/jc.86.12.5658

• CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2

  The Journal of Clinical Endocrinology & Metabolism · 2001 · https://doi.org/10.1210/jcem.86.12.8070

• Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

  Osteoporosis International · 2000 · https://doi.org/10.1007/s001980050010

Current projects

No projects listed.